Kraus & Lederer Partgmbb competitive analysis

Explore patent oppositions filed by Kraus & Lederer Partgmbb against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Feb 12, 2026
Patent NumberTitleApplicantOpposition Date
Manufacture Of A Crystalline Pharmaceutical ProductORIONJan 8, 2026
Treatment Of HypoparathyroidismENTERA BIODec 29, 2025
Propylene-Ethylene Random Copolymers With Low Xs/Et Ratio And High MfrW R GRACE & CONNNov 19, 2025
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 3, 2025
Cannabidiol Preparations And Its UsesGW RESEARCHJul 23, 2025
Use Of Cannabinoids In The Treatment Of Seizures Associated With Lennox-Gastaut SyndromeGW RESEARCHJul 8, 2025
Use Of Riluzole Prodrugs To Treat AtaxiasBIOHAVEN PHARMACEUTICAL HOLDINGJul 2, 2025
Method Of Treating Waste PlasticNESTE OYJJun 23, 2025
Method For The Treatment Of Plastic Pyrolysis Oils Including Single-Stage HydrocrackingIFP ENERGIES NOUVELLESJun 17, 2025
Process For The Preparation Of Polyethylenes From Waste Plastic FeedstocksSABICJun 4, 2025

Latest PTAB cases involving Kraus & Lederer Partgmbb

Discover the latest PTAB cases involving Kraus & Lederer Partgmbb, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Kraus & Lederer Partgmbb with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Feb 12, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
KRAUS & LEDERER PARTGMBB71 - - -
BOEHRINGER INGELHEIM49179109
BRISTOL MYERS SQUIBB - 69 - 8
GW RESEARCH - 6 - -